Related Experiment Video

Updated: Aug 30, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

[Continuous fenoterol inhalation by children with severe acute asthma: immediate clinical effects]

Lourdes Z Zanoni1, Durval B Palhares

  • 1Departamento de Pediatria, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS. lzzanoni@nin.ufms.br

Jornal De Pediatria
|December 4, 2003
PubMed

Insights

Continuous fenoterol inhalation in children with severe acute asthma can cause side effects like sleepiness and nausea. Close clinical monitoring is recommended during this treatment, especially for children with other health issues.

Area of Science:

  • Pediatric Pulmonology
  • Clinical Pharmacology
  • Emergency Medicine

Context:

  • Severe acute asthma is a critical condition in children requiring prompt and effective treatment.
  • Fenoterol is a bronchodilator used in asthma management, but its safety profile in continuous high-dose administration needs evaluation.
  • Pediatric intensive care settings necessitate careful monitoring of treatment side effects.

Purpose:

  • To assess the physiological and psychological effects of continuous fenoterol inhalation (0.5 mg/Kg) in pediatric patients with severe acute asthma.
  • To evaluate changes in heart rate, blood pressure, oxygen saturation, and psychological status post-inhalation.
  • To identify potential adverse events associated with this therapeutic approach.

Summary:

  • A study involving 30 children with severe acute asthma investigated the impact of continuous fenoterol inhalation (0.5 mg/Kg).
  • Observed effects included increased oxygen saturation, elevated heart rate, decreased blood pressure, and psychological symptoms like sleepiness, agitation, nausea, and vomiting.
  • The study highlights the need for vigilant clinical monitoring during fenoterol therapy in this population.

Impact:

  • The findings underscore the importance of continuous clinical monitoring for children receiving high-dose fenoterol for severe acute asthma.
  • Recommendations include special attention for patients with comorbidities such as diarrhea, vomiting, and dehydration.
  • This research informs clinical practice regarding the safe administration and management of fenoterol in pediatric asthma emergencies.
Abstract

More Related Videos

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...